ERYTHROCYTE THIOLMETHYLTRANSFERASE - ANOTHER FAILED MARKER FOR ALZHEIMERS AND PARKINSONS DISEASES

被引:4
|
作者
HURWITZ, A [1 ]
HUBBLE, JP [1 ]
GLATT, SL [1 ]
KOLLER, WC [1 ]
POLLACK, J [1 ]
机构
[1] UNIV KANSAS,MED CTR,DEPT NEUROL,KANSAS CITY,KS 66160
关键词
D O I
10.1212/WNL.45.10.1903
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
There are reports that patients with Parkinson's disease (PD) and Alzheimer's disease (AD) have reduced levels of thiolmethyltransferase (TMT) in erythrocyte membranes. TMT methylates thiols and thiocarbamates, thereby reducing their toxicity. We examined TMT levels in erythrocytes from patients with PD and AD and from age-matched controls. Specific activities of TMT were 564 +/- 199 U/mg protein in PD (n = 32), 513 +/- 118 in AD (n = 13), and 565 +/- 183 in controls (n = 35). There was no difference between any of the groups (p = 0.64). We failed to confirm TMT as a marker for neurodegenerative diseases or for this metabolic defect predisposing to susceptibility to neurotoxins.
引用
收藏
页码:1903 / 1906
页数:4
相关论文
共 50 条
  • [42] SERUM ALPHA-1-ANTICHYMOTRYPSIN IS NOT A USEFUL MARKER FOR ALZHEIMERS-DISEASE OR DEMENTIA IN PARKINSONS-DISEASE
    KUIPER, MA
    VANKAMP, GJ
    BERGMANS, PLM
    SCHELTENS, P
    WOLTERS, EC
    JOURNAL OF NEURAL TRANSMISSION-PARKINSONS DISEASE AND DEMENTIA SECTION, 1993, 6 (02) : 145 - 149
  • [43] CORTICAL SEROTONIN-S2 RECEPTOR-BINDING IN LEWY BODY DEMENTIA, ALZHEIMERS AND PARKINSONS DISEASES
    CHENG, AVT
    FERRIER, IN
    MORRIS, CM
    JABEEN, S
    SAHGAL, A
    MCKEITH, IG
    EDWARDSON, JA
    PERRY, RH
    PERRY, EK
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 1991, 106 (01) : 50 - 55
  • [44] BRAIN CALCIUM-CHANNEL RELATED DIHYDROPYRIDINE AND PHENYLALKYLAMINE BINDING-SITES IN ALZHEIMERS, PARKINSONS AND HUNTINGTONS DISEASES
    SEN, AP
    BOKSA, P
    QUIRION, R
    BRAIN RESEARCH, 1993, 611 (02) : 216 - 221
  • [45] EVALUATION OF ERYTHROCYTE HYPERAGGREGATION IN FETAL BLOOD DRAWN BY CORDOCENTESIS AS A MARKER OF FETAL DISEASES
    BRUN, JF
    ELBOUHMADI, A
    BOULOT, P
    ROUSSEAU, O
    LAFFARGUE, F
    VIALA, JL
    ORSETTI, A
    CLINICAL HEMORHEOLOGY, 1994, 14 (05): : 637 - 642
  • [46] RELATIONSHIP BETWEEN PARKINSONS AND ALZHEIMERS DISEASES - INVOLVEMENT OF EXTRA-PYRAMIDAL, DOPAMINERGIC, CHOLINERGIC AND SOMATOSTATIN MECHANISMS IN RELATION TO DEMENTIA
    RINNE, UK
    LAAKSO, K
    MOLSA, P
    PALJARVI, L
    PORTIN, R
    RINNE, JK
    RINNE, JO
    SAKO, E
    ACTA NEUROLOGICA SCANDINAVICA, 1984, 69 : 59 - 60
  • [47] ARE EXPLICIT MEMORY DISORDERS OF PROGRESSIVE SUPRANUCLEAR PALSY RELATED TO DAMAGE TO STRIATOFRONTAL CIRCUITS - COMPARISON WITH ALZHEIMERS, PARKINSONS, AND HUNTINGTONS DISEASES
    PILLON, B
    MICHON, A
    MALAPANI, C
    AGID, Y
    DUBOIS, B
    NEUROLOGY, 1994, 44 (07) : 1264 - 1270
  • [48] HUMAN MITOCHONDRIAL SUPEROXIDE-DISMUTASE - A LESS ACTIVE POLYMORPHIC FORM AND TYPE-II DIABETES, PARKINSONS AND ALZHEIMERS DISEASES
    HALLEWELL, RA
    BOISSINOT, M
    JOHNSON, M
    TAINER, JA
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 154 - 154
  • [49] IMMUNOCYTOCHEMICAL STUDIES OF SUBSTANCE-P AND MET-ENKEPHALIN IN THE BASAL GANGLIA AND SUBSTANTIA NIGRA IN HUNTINGTONS, PARKINSONS AND ALZHEIMERS DISEASES
    GRAFE, MR
    FORNO, LS
    ENG, LF
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1985, 44 (01): : 47 - 59
  • [50] Hyperuricemia: Just Another Marker of or Independent Risk Factor for Hypertension and Other Cardiovascular Diseases?
    Wallner, M.
    JOURNAL FUR HYPERTONIE, 2009, 13 (04): : 16 - 20